174 related articles for article (PubMed ID: 32383357)
1. PAK5 facilitates the proliferation, invasion and migration in colorectal cancer cells.
Huang S; Zhu Y; Wang C; Li X; Cui X; Tu S; You L; Fu J; Chen Z; Hu W; Gong W
Cancer Med; 2020 Jul; 9(13):4777-4790. PubMed ID: 32383357
[TBL] [Abstract][Full Text] [Related]
2. P21-activated kinase 5 is overexpressed during colorectal cancer progression and regulates colorectal carcinoma cell adhesion and migration.
Gong W; An Z; Wang Y; Pan X; Fang W; Jiang B; Zhang H
Int J Cancer; 2009 Aug; 125(3):548-55. PubMed ID: 19415746
[TBL] [Abstract][Full Text] [Related]
3. p21-activated kinase 5 inhibits camptothecin-induced apoptosis in colorectal carcinoma cells.
Wang X; Gong W; Qing H; Geng Y; Wang X; Zhang Y; Peng L; Zhang H; Jiang B
Tumour Biol; 2010 Dec; 31(6):575-82. PubMed ID: 20567954
[TBL] [Abstract][Full Text] [Related]
4. PAK5-mediated E47 phosphorylation promotes epithelial-mesenchymal transition and metastasis of colon cancer.
Zhu G; Li X; Guo B; Ke Q; Dong M; Li F
Oncogene; 2016 Apr; 35(15):1943-54. PubMed ID: 26212009
[TBL] [Abstract][Full Text] [Related]
5. PAK5 Induces EMT and Promotes Cell Migration and Invasion by Activating the PI3K/AKT Pathway in Ovarian Cancer.
Li D; Pan Y; Huang Y; Zhang P; Fang X
Anal Cell Pathol (Amst); 2018; 2018():8073124. PubMed ID: 30245957
[TBL] [Abstract][Full Text] [Related]
6. PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo.
Zhang YC; Huo FC; Wei LL; Gong CC; Pan YJ; Mou J; Pei DS
J Exp Clin Cancer Res; 2017 Oct; 36(1):146. PubMed ID: 29041983
[TBL] [Abstract][Full Text] [Related]
7. AKAP-9 promotes colorectal cancer development by regulating Cdc42 interacting protein 4.
Hu ZY; Liu YP; Xie LY; Wang XY; Yang F; Chen SY; Li ZG
Biochim Biophys Acta; 2016 Jun; 1862(6):1172-81. PubMed ID: 27039663
[TBL] [Abstract][Full Text] [Related]
8. Extracellular translationally controlled tumor protein promotes colorectal cancer invasion and metastasis through Cdc42/JNK/ MMP9 signaling.
Xiao B; Chen D; Luo S; Hao W; Jing F; Liu T; Wang S; Geng Y; Li L; Xu W; Zhang Y; Liao X; Zuo D; Wu Y; Li M; Ma Q
Oncotarget; 2016 Aug; 7(31):50057-50073. PubMed ID: 27367023
[TBL] [Abstract][Full Text] [Related]
9. POTEE promotes colorectal carcinoma progression via activating the Rac1/Cdc42 pathway.
Xu Q; Chen J; Peng M; Duan S; Hu Y; Guo D; Geng J; Zhou J
Exp Cell Res; 2020 May; 390(1):111933. PubMed ID: 32142855
[TBL] [Abstract][Full Text] [Related]
10. PAK5-Egr1-MMP2 signaling controls the migration and invasion in breast cancer cell.
Wang XX; Cheng Q; Zhang SN; Qian HY; Wu JX; Tian H; Pei DS; Zheng JN
Tumour Biol; 2013 Oct; 34(5):2721-9. PubMed ID: 23696025
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of PAK5 inhibits glioma cell migration and invasion potentially through the PAK5-Egr1-MMP2 signaling pathway.
Han ZX; Wang XX; Zhang SN; Wu JX; Qian HY; Wen YY; Tian H; Pei DS; Zheng JN
Brain Tumor Pathol; 2014 Oct; 31(4):234-41. PubMed ID: 24062079
[TBL] [Abstract][Full Text] [Related]
12. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
[TBL] [Abstract][Full Text] [Related]
13. miR-129 suppresses tumor cell growth and invasion by targeting PAK5 in hepatocellular carcinoma.
Zhai J; Qu S; Li X; Zhong J; Chen X; Qu Z; Wu D
Biochem Biophys Res Commun; 2015 Aug; 464(1):161-7. PubMed ID: 26116538
[TBL] [Abstract][Full Text] [Related]
14. PAK5 promotes RNA helicase DDX5 sumoylation and miRNA-10b processing in a kinase-dependent manner in breast cancer.
Li Y; Xing Y; Wang X; Hu B; Zhao X; Zhang H; Han F; Geng N; Wang F; Li Y; Li J; Jin F; Li F
Cell Rep; 2021 Dec; 37(12):110127. PubMed ID: 34936874
[TBL] [Abstract][Full Text] [Related]
15. Human p21-activated kinase 5 (PAK5) expression and potential mechanisms in relevant cancers: Basic and clinical perspectives for molecular cancer therapeutics.
Li YK; Zou J; Ye DM; Zeng Y; Chen CY; Luo GF; Zeng X
Life Sci; 2020 Jan; 241():117113. PubMed ID: 31805288
[TBL] [Abstract][Full Text] [Related]
16. PAK5 promotes the migration and invasion of cervical cancer cells by phosphorylating SATB1.
Huo FC; Pan YJ; Li TT; Mou J; Pei DS
Cell Death Differ; 2019 Jun; 26(6):994-1006. PubMed ID: 30082769
[TBL] [Abstract][Full Text] [Related]
17. ITGBL1 promotes migration, invasion and predicts a poor prognosis in colorectal cancer.
Qiu X; Feng JR; Qiu J; Liu L; Xie Y; Zhang YP; Liu J; Zhao Q
Biomed Pharmacother; 2018 Aug; 104():172-180. PubMed ID: 29772438
[TBL] [Abstract][Full Text] [Related]
18. An oncogenic kinase: putting PAK5 forward.
Wen YY; Zheng JN; Pei DS
Expert Opin Ther Targets; 2014 Jul; 18(7):807-15. PubMed ID: 24869804
[TBL] [Abstract][Full Text] [Related]
19. High expression of protein phosphatase 4 is associated with the aggressive malignant behavior of colorectal carcinoma.
Li X; Liang L; Huang L; Ma X; Li D; Cai S
Mol Cancer; 2015 Apr; 14():95. PubMed ID: 25927939
[TBL] [Abstract][Full Text] [Related]
20. miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway.
Niu Y; Zhang J; Tong Y; Li J; Liu B
Int J Biochem Cell Biol; 2019 Dec; 117():105641. PubMed ID: 31693935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
